Chugai Pharmaceutical and Omron Corporation have joined forces to automate research processes with the goal of enhancing the productivity of drug discovery research, improving the quality of experimental data, and enabling new experimental activities.
This collaboration involves the implementation of a system at Chugai Life Science Park Yokohama, where it will undergo verification tests and be utilised for fundamental drug discovery research operations.
The system will utilise robotic technologies and artificial intelligence (AI) to streamline various tasks. Mobile robots will be responsible for transporting laboratory samples and controlling equipment, while dual arm robots will handle the operation of a diverse range of experimental tools.
By automating these processes, the system has the potential to operate even during unstaffed periods, such as overnight, allowing drug discovery experiments to continue uninterrupted.
This collaboration represents a promising step forward in incorporating AI-assisted drug discovery and robotic technologies into the research process, promising considerable gains in research productivity and the quality of outcomes.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!